A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients

Background The safety and tolerability of a mite allergoid subcutaneous allergen immunotherapy (SCIT) product was previously established. The aim of this study (EudraCT number: 2011-000393-61) was to find the optimally safe and effective allergoid dose by evaluating several dosages in patients with...

Full description

Saved in:
Bibliographic Details
Main Author: Pfaar, Oliver (Author)
Format: Article (Journal)
Language:English
Published: 10 February 2016
In: Allergy
Year: 2016, Volume: 71, Issue: 7, Pages: 967-976
ISSN:1398-9995
DOI:10.1111/all.12860
Online Access:Verlag, Volltext: https://doi.org/10.1111/all.12860
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/all.12860
Get full text
Author Notes:O. Pfaar, M.J. Nell, J.D. Boot, S.A. Versteeg, R. van Ree, A. Roger, H. Riechelmann, A. Sperl, J.N.G. Oude Elberink, Z. Diamant and C. Bachert

MARC

LEADER 00000caa a2200000 c 4500
001 1668810484
003 DE-627
005 20220816185423.0
007 cr uuu---uuuuu
008 190709s2016 xx |||||o 00| ||eng c
024 7 |a 10.1111/all.12860  |2 doi 
035 |a (DE-627)1668810484 
035 |a (DE-599)KXP1668810484 
035 |a (OCoLC)1341233210 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Pfaar, Oliver  |d 1972-  |e VerfasserIn  |0 (DE-588)12385900X  |0 (DE-627)706454049  |0 (DE-576)293913099  |4 aut 
245 1 2 |a A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients  |c O. Pfaar, M.J. Nell, J.D. Boot, S.A. Versteeg, R. van Ree, A. Roger, H. Riechelmann, A. Sperl, J.N.G. Oude Elberink, Z. Diamant and C. Bachert 
264 1 |c 10 February 2016 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.07.2019 
520 |a Background The safety and tolerability of a mite allergoid subcutaneous allergen immunotherapy (SCIT) product was previously established. The aim of this study (EudraCT number: 2011-000393-61) was to find the optimally safe and effective allergoid dose by evaluating several dosages in patients with house dust mite (HDM)-induced allergic rhinoconjunctivitis (ARC) using a titrated nasal provocation test (TNPT). Methods In total, 290 adult ARC patients (148 females; 142 males) with established HDM allergy and with a positive TNPT were randomized to receive placebo or mite allergoid SCIT 6667, 20 000, 50 000 or 100 000 AUeq/ml for 12 months. Patients were updosed weekly, followed by monthly maintenance dosing. The primary study endpoint comprised the clinical response to TNPT after 12 months of treatment. Secondary endpoints included response to TNPT after 6 months, PNIF measurements, symptom and medication scores during the last 8 weeks of treatment, serum immunoglobulins and safety assessments. Results After 12 months, a dose-response was observed showing statistically significant improvements in the TNPT with SCIT concentrations of ≥20 000 AUeq/ml, while no significantly different outcomes were reached after 6 months. Specific serum IgG and IgG4 levels were dose dependently increased. In the highest dose group, more treatment-emergent adverse events were observed compared with the lower dose groups. Conclusion In this mite allergoid SCIT dose finding study in HDM-induced ARC, concentrations of ≥20 000 AUeq/ml showed both immunological effects and clinical efficacy in the TNPT compared with placebo. The risk-benefit ratio favours 20 000 AUeq/ml and 50 000 AUeq/ml strengths for further clinical development. 
650 4 |a allergic rhinoconjunctivitis 
650 4 |a allergoid 
650 4 |a dose finding 
650 4 |a house dust mites 
650 4 |a subcutaneous immunotherapy 
773 0 8 |i Enthalten in  |t Allergy  |d Oxford : Wiley, 1978  |g 71(2016), 7, Seite 967-976  |h Online-Ressource  |w (DE-627)320425428  |w (DE-600)2003114-2  |w (DE-576)091140153  |x 1398-9995  |7 nnas  |a A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients 
773 1 8 |g volume:71  |g year:2016  |g number:7  |g pages:967-976  |g extent:10  |a A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients 
856 4 0 |u https://doi.org/10.1111/all.12860  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/all.12860  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190709 
993 |a Article 
994 |a 2016 
998 |g 12385900X  |a Pfaar, Oliver  |m 12385900X:Pfaar, Oliver  |d 60000  |d 62100  |e 60000PP12385900X  |e 62100PP12385900X  |k 0/60000/  |k 1/60000/62100/  |p 1  |x j 
999 |a KXP-PPN1668810484  |e 3492155308 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["O. Pfaar, M.J. Nell, J.D. Boot, S.A. Versteeg, R. van Ree, A. Roger, H. Riechelmann, A. Sperl, J.N.G. Oude Elberink, Z. Diamant and C. Bachert"]},"origin":[{"dateIssuedDisp":"10 February 2016","dateIssuedKey":"2016"}],"id":{"eki":["1668810484"],"doi":["10.1111/all.12860"]},"physDesc":[{"extent":"10 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Oxford ; Oxford","dateIssuedDisp":"1978-","dateIssuedKey":"1978","publisher":"Wiley ; Blackwell Munksgaard"}],"id":{"issn":["1398-9995"],"zdb":["2003114-2"],"doi":["10.1111/(ISSN)1398-9995"],"eki":["320425428"]},"note":["Gesehen am 14.08.14"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patientsAllergy","language":["eng"],"recId":"320425428","pubHistory":["33.1978 -"],"part":{"pages":"967-976","issue":"7","year":"2016","extent":"10","text":"71(2016), 7, Seite 967-976","volume":"71"},"title":[{"title":"Allergy","title_sort":"Allergy"}]}],"person":[{"given":"Oliver","family":"Pfaar","role":"aut","display":"Pfaar, Oliver","roleDisplay":"VerfasserIn"}],"title":[{"title":"A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients","title_sort":"randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 09.07.2019"],"language":["eng"],"recId":"1668810484"} 
SRT |a PFAAROLIVERANDOMIZED1020